Titan Pharmaceuticals Announces Phase 3 Probuphine(R) Data Presentation at the American Society of Addiction Medicine (ASAM) 43rd Medical-Scientific Conference April 20, 2012
Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2011 Financial Results March 14, 2012
Titan Pharmaceuticals to Participate in RBC Capital Markets Global Healthcare Conference February 23, 2012
Titan Pharmaceuticals Announces Positive Results of Six-Month Open-Label Safety Retreatment Study of Probuphine February 9, 2012
Titan Pharmaceuticals Adopts Stockholder Rights Plan, Files Shelf Registration of Securities on Form S-3 December 21, 2011
Titan Pharmaceuticals Announces Probuphine Presentation at American Society of Addiction Medicine Conference October 20, 2011
